COMPUTATIONAL INSIGHTS INTO THE BINDING EFFICIENCY OF PHYTOCOMPOUNDS IN ERANDADI KWATHAM: A MOLECULAR DOCKING APPROACH
AbstractRheumatoid arthritis (RA) is a chronic inflammation disorder that primarily affects the joints and leads to the progressive destruction of joints, synovial hyperplasia bone, and cartilage degeneration. Globally 1% of the world population was affected by rheumatoid arthritis. The present study focused to identify the bioactive phytocompounds of polyherbal formulation- Erandadi Kwatham and to determine its potential in inhibiting the targets TNF-α and Hk-II, which are associated with rheumatoid arthritis. The 3D structure of the phytocompounds were retrieved and analyzed for its physicochemical properties, toxicity, and drug-likeness were determined using the Qikprop module in maestro Schrodinger software. Among, only six compounds satisfied the ADME properties and followed drug-likeness. Further the phytocompounds triethyl citrate (6506), butanedioic acid, hydroxyl diethyl ester (24197), L-Valine, ethyl ester (87182), phenylacetic acid (97942), 7-trihydroxy-1-methyl – 8 – methylene-1, 4a-lactone-10-methyl (539615), and pectolinarigenin (5320438), were analyzed using molecular docking studies against the protein targets, TNF-α and Hk-II. The compounds triethyl citrate and pectolinarigenin were observed with significant binding efficiency of -3.47 and -5.88 kcal/mol against the respective targets TNF-α (2az5) and Hk-II (2nzt). In conclusion, the reported compounds could be further considered for molecular dynamics to evaluate its stability and respective experimental analysis, therefore to be considered as an effective alternative for treating rheumatoid arthritis.
Article Information
12
944-952
873 KB
32
English
IJPSR
S. Shamina *, Rajesh Sivamoorthy, R. Sathish Kumar and Sharanya Manoharan
Department of Biochemistry, R. V. S. College of Arts and Science, Coimbatore, Tamil Nadu, India.
shaminabc26@gmail.com
27 March 2024
10 March 2025
14 March 2025
10.13040/IJPSR.0975-8232.16(4).944-52
01 April 2025